| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |